Journal of Neurology

, Volume 259, Issue 1, pp 193–195 | Cite as

No evidence for an association between genetic variation at the MMP2 and MMP9 loci and aneurysmal subarachnoid haemorrhage

  • Sandra Olsson
  • Ludvig Z. Csajbok
  • Katarina Jood
  • Karin Nylén
  • Bengt Nellgård
  • Christina Jern
Letter to the Editors

References

  1. 1.
    Ferro JM, Canhao P, Peralta R (2008) Update on subarachnoid haemorrhage. J Neurol 255:465–479PubMedCrossRefGoogle Scholar
  2. 2.
    Nahed BV, Bydon M, Ozturk AK, Bilguvar K, Bayrakli F, Gunel M (2007) Genetics of intracranial aneurysms. Neurosurgery 60:213–225PubMedCrossRefGoogle Scholar
  3. 3.
    Kim SC, Singh M, Huang J, Prestigiacomo CJ, Winfree CJ, Solomon RA, Connolly ES Jr (1997) Matrix metalloproteinase-9 in cerebral aneurysms. Neurosurgery 41:642–666PubMedGoogle Scholar
  4. 4.
    Jin D, Sheng J, Yang X, Gao B (2007) Matrix metalloproteinases and tissue inhibitors of metalloproteinases expression in human cerebral ruptured and unruptured aneurysm. Surg Neurol 68(Suppl 2):S11–S17Google Scholar
  5. 5.
    Nylén K, Csajbok LZ, Ost M, Rashid A, Blennow K, Nellgård B, Rosengren L (2007) Serum glial fibrillary acidic protein is related to focal brain injury and outcome after aneurysmal subarachnoid hemorrhage. Stroke 38:1489–1494PubMedCrossRefGoogle Scholar
  6. 6.
    Ladenvall C, Csajbok L, Nylén K, Jood K, Nellgård B, Jern C (2009) Association between factor XIII single nucleotide polymorphisms and aneurysmal subarachnoid hemorrhage. J Neurosurg 110:475–481PubMedCrossRefGoogle Scholar
  7. 7.
    Krex D, Kotteck K, König IR, Ziegler A, Schackert HK, Schackert G (2004) Matrix metalloproteinase-9 coding sequence single-nucleotide polymorphisms in Caucasians with intracranial aneurysms. Neurosurgery 55:207–212PubMedCrossRefGoogle Scholar
  8. 8.
    Yoon S, Tromp G, Vongpunsawad S, Ronkainen A, Juvonen T, Kuivaniemi H (1999) Genetic analysis of MMP3, MMP9, and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms. Biochem Biophys Res Commun 265:563–568PubMedCrossRefGoogle Scholar
  9. 9.
    Zhang B, Dhillon S, Geary I, Howell WM, Iannotti F, Day IN, Ye S (2001) Polymorphisms in matrix metalloproteinase-1, -3, -9, and -12 genes in relation to subarachnoid hemorrhage. Stroke 32:2198–2202PubMedCrossRefGoogle Scholar
  10. 10.
    Kaplan RC, Smith NL, Zucker S, Heckbert SR, Rice K, Psaty BM (2008) Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic stroke. Atherosclerosis 201:130–137PubMedCrossRefGoogle Scholar
  11. 11.
    Pannu H, Kim DH, Guo D, King TM, Van Ginhoven G, Chin T, Chang K, Qi Y, Shete S, Milewicz DM (2006) The role of MMP-2 and MMP-9 polymorphisms in sporadic intracranial aneurysms. J Neurosurg 105:418–423PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Sandra Olsson
    • 1
  • Ludvig Z. Csajbok
    • 1
  • Katarina Jood
    • 1
  • Karin Nylén
    • 1
  • Bengt Nellgård
    • 1
  • Christina Jern
    • 1
  1. 1.Department of Clinical Neuroscience and Rehabilitation, Institute of Neuroscience and PhysiologyThe Sahlgrenska Academy at University of GothenburgGothenburgSweden

Personalised recommendations